article thumbnail

Modulation of NOX2 causes obesity-mediated atrial fibrillation

Journal of Clinical Investigation - Cardiology

Obesity is linked to an increased risk of atrial fibrillation (AF) via increased oxidative stress. Here, we studied NOX2-mediated ROS production in obesity-mediated AF using Nox2-knockout mice and mature human induced pluripotent stem cell–derived atrial cardiomyocytes (hiPSC-aCMs).

article thumbnail

Dual vs Single Cardioversion of Atrial Fibrillation in Patients With Obesity

JAMA Cardiology

This randomized clinical trial investigates which strategy is more effective in patients with atrial fibrillation and obesity: dual or single direct-current cardioversion.

article thumbnail

Convergent approach to persistent atrial fibrillation ablation: long-term single-centre safety and efficacy

Frontiers in Cardiovascular Medicine

Background Efforts to maintain sinus rhythm in patients with persistent atrial fibrillation (PsAF) remain challenging, with suboptimal long-term outcomes. Twelve (50%) patients were obese. Methods All patients undergoing convergent PsAF ablation at our centre were retrospectively analysed. All were longstanding persistent.

article thumbnail

Challenges in the Cardiovascular Evaluation and Management of Patients With Obesity

American College of Cardiology

Obesity is a multifaceted disease that is directly and indirectly implicated in atherosclerotic cardiovascular disease (CVD), heart failure (HF), atrial fibrillation (AF), and multiple CVD risk factors, including dyslipidemia, hypertension, type 2 diabetes mellitus (DM), and sleep disorders.

Obesity 71
article thumbnail

Why is obesity linked to irregular heart rhythms? Researchers found one potential mechanism

Medical Xpress - Cardiology

Atrial fibrillation, or A-fib, is an irregular heart rhythm that increases a person's risk of stroke, heart failure and even premature death.

article thumbnail

Dual vs. Single Cardioversion in Patients With Obesity

American College of Cardiology

The goal of the Dual vs. Single DCCV trial was to determine the efficacy and safety of dual direct-current cardioversion (DCCV) compared with single DCCV in patients with obesity and atrial fibrillation (AF) undergoing elective electrical cardioversion.

Obesity 58
article thumbnail

Health Care Resource Use and Costs of Rivaroxaban Versus Warfarin Among Nonvalvular Atrial Fibrillation Polypharmacy Patients With Obesity

Journal of the American Heart Association

BackgroundThe economic burden of nonvalvular atrial fibrillation (NVAF) is substantial. Many patients with NVAF are obese and manage other health conditions requiring multiple medications. Journal of the American Heart Association, Ahead of Print.